- Home
- MTNB vs WAI Comparison
MTNB vs WAI Comparison
Compare MTNB & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- WAI
- Stock Information
- Founded
- MTNB 2013
- WAI 2018
- Country
- MTNB United States
- WAI China
- Employees
- MTNB N/A
- WAI N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- WAI
- Sector
- MTNB Health Care
- WAI
- Exchange
- MTNB Nasdaq
- WAI NYSE
- Market Cap
- MTNB 5.2M
- WAI 5.5M
- IPO Year
- MTNB N/A
- WAI 2023
- Fundamental
- Price
- MTNB $0.93
- WAI $0.48
- Analyst Decision
- MTNB Hold
- WAI
- Analyst Count
- MTNB 1
- WAI 0
- Target Price
- MTNB N/A
- WAI N/A
- AVG Volume (30 Days)
- MTNB 52.1K
- WAI 5.9M
- Earning Date
- MTNB 08-13-2025
- WAI 08-24-2025
- Dividend Yield
- MTNB N/A
- WAI N/A
- EPS Growth
- MTNB N/A
- WAI N/A
- EPS
- MTNB N/A
- WAI N/A
- Revenue
- MTNB N/A
- WAI $3,750,352.00
- Revenue This Year
- MTNB N/A
- WAI N/A
- Revenue Next Year
- MTNB N/A
- WAI N/A
- P/E Ratio
- MTNB N/A
- WAI N/A
- Revenue Growth
- MTNB N/A
- WAI N/A
- 52 Week Low
- MTNB $0.47
- WAI $0.41
- 52 Week High
- MTNB $8.75
- WAI $20.00
- Technical
- Relative Strength Index (RSI)
- MTNB 48.75
- WAI N/A
- Support Level
- MTNB $0.94
- WAI N/A
- Resistance Level
- MTNB $1.04
- WAI N/A
- Average True Range (ATR)
- MTNB 0.07
- WAI 0.00
- MACD
- MTNB -0.01
- WAI 0.00
- Stochastic Oscillator
- MTNB 20.07
- WAI 0.00
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).